Jeffrey S. Hackman, Chief Executive Officer at FENNEC PHARMACEUTICALS INC. (FENC), bought 28,965 shares at $6.99 ($202K) on 2025-05-19, disclosed to the SEC on 2025-05-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.75 | 1,035 | $7K | 3.5% |
| 2 | $6.99 | 13,965 | $98K | 48.3% |
| 3 | $6.99 | 13,965 | $98K | 48.3% |
| Total | $6.98 avg | 28,965 | $202K | 100% |